BIOATLA INC (BCAB) Stock Cash Flow
NASDAQ:BCAB - Nasdaq - US09077B1044 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -69.78M | -123.46M | -106.48M | -95.40M | -35.85M | |||
| Depreciation Amortization | 925.00K | 1.22M | 1.20M | 1.33M | 1.01M | |||
| Change In Working Capital | -11.20M | 4.68M | 290.00K | 7.42M | -3.36M | |||
| Other non cash items | 8.11M | 13.55M | 14.58M | 24.43M | 1.87M | |||
| OPERATING CASH FLOW | -71.94M | -104.02M | -90.42M | -62.21M | -36.33M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | 0.00 | -98.00K | -270.00K | -920.00K | -590.00K | |||
| Other Investing Activity | N/A | 0.00 | 0.00 | N/A | N/A | |||
| INVESTING CASH FLOW | 0.00 | -98.00K | -270.00K | -920.00K | -590.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | 0.00 | 3.43M | |||
| Stock Issued/Repurchased | 9.56M | 336.00K | 61.97M | 71.42M | 68.18M | |||
| Other Financing Activity | -46.00K | -259.00K | -760.00K | -1.91M | 200.21M | |||
| FINANCING CASH FLOW | 9.51M | 77.00K | 61.21M | 69.51M | 271.83M | |||
| CHANGE IN CASH | -62.42M | -104.04M | -29.48M | 6.38M | 234.91M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -71.94M | -104.02M | -90.42M | -62.21M | -36.33M | |||
| Capital Expenditure | 0.00 | -98.00K | -270.00K | -920.00K | -590.00K | |||
| FREE CASH FLOW | -71.94M | -104.11M | -90.69M | -63.13M | -36.92M | |||
All data in USD